Plus Therapeutics, Inc is a biotechnology business based in the US. Plus Therapeutics shares (PSTV) are listed on the NASDAQ and all prices are listed in US Dollars. Plus Therapeutics employs 12 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Plus Therapeutics
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – PSTV – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
Plus Therapeutics stock price (NASDAQ: PSTV)Use our graph to track the performance of PSTV stocks over time.
Plus Therapeutics shares at a glance
|Latest market close||$2.37|
|52-week range||$1.92 - $4.10|
|50-day moving average||$2.55|
|200-day moving average||$2.53|
|Wall St. target price||$6.81|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-27.98|
Buy Plus Therapeutics shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Plus Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Plus Therapeutics price performance over time
|1 week (2021-07-14)||N/A|
|1 month (2021-06-25)||-15.36%|
|3 months (2021-04-21)||N/A|
|6 months (2021-01-21)||N/A|
|1 year (2020-07-21)||N/A|
|2 years (2019-07-21)||N/A|
|3 years (2018-07-21)||N/A|
|5 years (2016-07-21)||N/A|
Plus Therapeutics financials
|Gross profit TTM||$-2,397,000|
|Return on assets TTM||-28.12%|
|Return on equity TTM||-205.75%|
|Market capitalisation||$21.9 million|
TTM: trailing 12 months
Shorting Plus Therapeutics shares
There are currently 326,721 Plus Therapeutics shares held short by investors – that's known as Plus Therapeutics's "short interest". This figure is 3.9% down from 340,073 last month.
There are a few different ways that this level of interest in shorting Plus Therapeutics shares can be evaluated.
Plus Therapeutics's "short interest ratio" (SIR)
Plus Therapeutics's "short interest ratio" (SIR) is the quantity of Plus Therapeutics shares currently shorted divided by the average quantity of Plus Therapeutics shares traded daily (recently around 336825.77319588). Plus Therapeutics's SIR currently stands at 0.97. In other words for every 100,000 Plus Therapeutics shares traded daily on the market, roughly 970 shares are currently held short.
However Plus Therapeutics's short interest can also be evaluated against the total number of Plus Therapeutics shares, or, against the total number of tradable Plus Therapeutics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Plus Therapeutics's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Plus Therapeutics shares in existence, roughly 30 shares are currently held short) or 0.0155% of the tradable shares (for every 100,000 tradable Plus Therapeutics shares, roughly 16 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Plus Therapeutics.
Find out more about how you can short Plus Therapeutics stock.
Plus Therapeutics share dividends
We're not expecting Plus Therapeutics to pay a dividend over the next 12 months.
Have Plus Therapeutics's shares ever split?
Plus Therapeutics's shares were split on a 1:50 basis on 5 August 2019. So if you had owned 50 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Plus Therapeutics shares – just the quantity. However, indirectly, the new 4900% higher share price could have impacted the market appetite for Plus Therapeutics shares which in turn could have impacted Plus Therapeutics's share price.
Plus Therapeutics share price volatility
Over the last 12 months, Plus Therapeutics's shares have ranged in value from as little as $1.92 up to $4.1. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Plus Therapeutics's is 0.3945. This would suggest that Plus Therapeutics's shares are less volatile than average (for this exchange).
Plus Therapeutics overview
Plus Therapeutics, Inc. , a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer and other diseases. Its lead drug candidate is Rhenium NanoLiposomes, a patented radiotherapy for patients with recurrent glioblastoma, which is in the Phase 1 dose-finding clinical trial. The company is also developing DocePLUS, a patented chemotherapy for patients with solid tumors that is in Phase 1 clinical trial; and DoxoPLUS, a generic chemotherapy for patients with ovarian cancer. It has a license agreement with NanoTx, Corp. to develop and commercialize NanoTx's glioblastoma treatment. The company was formerly known as Cytori Therapeutics, Inc.
Plus Therapeutics in the news
Plus Therapeutics, Inc. (PSTV) CEO Marc Hedrick on Q2 2021 Results - Earnings Call Transcript
Plus Therapeutics Reports Second Quarter 2021 Financial Results and Business Highlights
Plus: Q2 Earnings Snapshot
Frequently asked questionsWhat percentage of Plus Therapeutics is owned by insiders or institutions?
Currently 2.744% of Plus Therapeutics shares are held by insiders and 3.76% by institutions. How many people work for Plus Therapeutics?
Latest data suggests 12 work at Plus Therapeutics. When does the fiscal year end for Plus Therapeutics?
Plus Therapeutics's fiscal year ends in December. Where is Plus Therapeutics based?
Plus Therapeutics's address is: 4200 Marathon Boulevard, Austin, TX, United States, 78756 What is Plus Therapeutics's ISIN number?
Plus Therapeutics's international securities identification number is: US72941H4002 What is Plus Therapeutics's CUSIP number?
Plus Therapeutics's Committee on Uniform Securities Identification Procedures number is: 23283K105
More guides on Finder
How to buy Clover Finance (CLV) in the US
This guide will show you step-by-step instructions on how to buy the Clover Finance (CLV) token as well as a list of exchanges you can trade it on.
How to buy AT-and-T (T) stock
Steps to owning and managing T, with 24-hour and historical pricing before you buy.
How to buy Hellenic Coin (HNC) in the US
This guide will show you step-by-step instructions on how to buy the Hellenic Coin (HNC) token as well as a list of exchanges you can trade it on.
How to buy Maro (MARO) in the US
This guide will show you step-by-step instructions on how to buy the Maro (MARO) token as well as a list of exchanges you can trade it on.
How to buy Ethernity Chain (ERN) in the US
This guide will show you step-by-step instructions on how to buy the Ethernity Chain (ERN) token as well as a list of exchanges you can trade it on.
How to buy Shopping.io (SPI) in the US
This guide will show you step-by-step instructions on how to buy the Shopping.io (SPI) token as well as a list of exchanges you can trade it on.
How to buy LUKSO Token (LYXE) in the US
This guide will show you step-by-step instructions on how to buy the LUKSO Token (LYXE) token as well as a list of exchanges you can trade it on.
How to buy KardiaChain (KAI) in the US
This guide will show you step-by-step instructions on how to buy the KardiaChain (KAI) token as well as a list of exchanges you can trade it on.
How to buy Neutrino USD (USDN) in the US
This guide will show you step-by-step instructions on how to buy the Neutrino USD (USDN) token as well as a list of exchanges you can trade it on.
How to buy Venus BTC (VBTC) in the US
This guide will show you step-by-step instructions on how to buy the Venus BTC (VBTC) token as well as a list of exchanges you can trade it on.
Ask an Expert